Virulence profiling and disease association of verocytotoxin-producing Escherichia coli O157 and non-O157 isolates in Belgium

Foodborne Pathogens and Disease

Volumn 9, Issue 6, 2012, Pages 530-535

  Buvens, Glenn ^a   Piérard, Denis ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BELGIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; ESCHERICHIA COLI O157; FECES; GENE CLUSTER; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PATHOGENICITY ISLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; SEROLOGY; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

BELGIUM; DYSENTERY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FECES; FOODBORNE DISEASES; GENES, BACTERIAL; GENETIC VARIATION; GENOMIC ISLANDS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; SEROTYPING; SHIGA TOXINS; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 84861983467     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2011.1073     Document Type: Article

References (19)

1. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: A microbiological study. Lancet Infect Dis 2011;11:671-676.
2. Brunder W, Schmidt H, Frosch M, Karch H. The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 1999;145:1005-1014. (Pubitemid 29231803)
3. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 2008;74:2153-2160. (Pubitemid 351522070)
4. Coombes BK, Gilmour MW, Goodman CD. The evolution of virulence in non-O157 Shiga toxin-producing Escherichia coli. Front Microbiol 2011;2:90.
5. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000;54:641-679.
6. Hedican EB, Medus C, Besser JM, Juni BA, Koziol B, Taylor C, Smith KE. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis 2009;49:358-364.
7. Karama M, Johnson RP, Holtslander R, Gyles CL. Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans. Appl Environm Microbiol 2009;75:268-270.
8. Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 2005;295:405-418. (Pubitemid 41225453)
9. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003;41:4930-4940. (Pubitemid 37429898)
10. Morabito S, Tozzoli R, Oswald E, Caprioli A. A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli. Infect Immun 2003;71:3343-3348. (Pubitemid 36637561)
11. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, Tobe T, Hattori M, Hayashi T. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA 2009;106:17939-17944.
12. Paton AW, Paton JC. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol 2002;40:271-274. (Pubitemid 34027638)
13. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 2004;200:35-46. (Pubitemid 38924726)
14. Perna NT, Plunkett G 3rd, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Pósfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 2001;409:529-533. (Pubitemid 32144360)
15. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin CS, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Møller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK. Origins of the E. coli strain causing an outbreak of hemolytic uremic syndrome in Germany. N Engl J Med 2011;365: 709-717.
16. Scheutz F, Nielsen EM, Frimodt-Møller J, Boisen N, Morabito S, Tozzoli R, Nataro JP, Caprioli A. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill 2011;16:pii = 19889.
17. Schmidt H, Scheef J, Huppertz HI, Frosch M, Karch H. Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: Phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 1999;37:3491-3496. (Pubitemid 29491080)
18. [WHO] World Health Organization. Zoonotic non-O157 Shiga toxin-producing Escherichia coli (STEC). In: Report of a WHO Scientific Workshop Group Meeting. Berlin: WHO.
19. Wickham ME, Lupp C, Mascarenhas M, Vazquez A, Coombes BK, Brown NF, Coburn BA, Deng W, Puente JL, Karmali MA, Finlay BB. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 2006;194:819-827. (Pubitemid 44344131)